Qorvo, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Qorvo, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $3.72B | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $3.77B | May 19, 2025 |
| FY2025 | Apr 1, 2023 | $3.57B | May 19, 2025 |
| FY2024 | Apr 2, 2022 | $4.65B | May 20, 2024 |
| FY2023 | Apr 3, 2021 | $4.02B | May 19, 2023 |
| FY2020 | Mar 28, 2020 | $787.77M | May 20, 2020 |
| FY2020 | Dec 28, 2019 | $869.07M | May 20, 2020 |
| FY2020 | Sep 28, 2019 | $806.70M | May 20, 2020 |
| FY2020 | Jun 29, 2019 | $775.60M | May 20, 2020 |
| FY2020 | Mar 30, 2019 | $680.88M | May 20, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $665.38M | May 21, 2018 |
| FY2018 | Dec 30, 2017 | $845.74M | May 21, 2018 |
| FY2018 | Sep 30, 2017 | $821.58M | May 21, 2018 |
| FY2018 | Jul 1, 2017 | $640.83M | May 21, 2018 |
| FY2018 | Apr 1, 2017 | $642.99M | May 21, 2018 |
| FY2018 | Dec 31, 2016 | $826.35M | May 21, 2018 |
| FY2018 | Oct 1, 2016 | $864.70M | May 21, 2018 |
| FY2018 | Jul 2, 2016 | $698.54M | May 21, 2018 |
| FY2016 | Apr 2, 2016 | $608.07M | May 31, 2016 |
| FY2016 | Jan 2, 2016 | $620.68M | May 31, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $1.54B | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $1.49B | May 19, 2025 |
| FY2025 | Apr 1, 2023 | $1.30B | May 19, 2025 |
| FY2024 | Apr 2, 2022 | $2.29B | May 20, 2024 |
| FY2023 | Apr 3, 2021 | $1.88B | May 19, 2023 |
| FY2020 | Mar 28, 2020 | $335.78M | May 20, 2020 |
| FY2020 | Dec 28, 2019 | $368.11M | May 20, 2020 |
| FY2020 | Sep 28, 2019 | $323.58M | May 20, 2020 |
| FY2020 | Jun 29, 2019 | $294.29M | May 20, 2020 |
| FY2020 | Mar 30, 2019 | $266.57M | May 20, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $55.62M | May 19, 2025 |
| FY2025 | Mar 30, 2024 | ($70.32M) | May 19, 2025 |
| FY2025 | Apr 1, 2023 | $103.15M | May 19, 2025 |
| FY2024 | Apr 2, 2022 | $1.03B | May 20, 2024 |
| FY2023 | Apr 3, 2021 | $733.61M | May 19, 2023 |
| FY2020 | Mar 28, 2020 | $50.39M | May 20, 2020 |
| FY2020 | Dec 28, 2019 | $161.36M | May 20, 2020 |
| FY2020 | Sep 28, 2019 | $83.04M | May 20, 2020 |
| FY2020 | Jun 29, 2019 | $39.54M | May 20, 2020 |
| FY2020 | Mar 30, 2019 | $61.52M | May 20, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $95.53M | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $91.70M | May 19, 2025 |
| FY2025 | Apr 1, 2023 | $183.17M | May 19, 2025 |
| FY2024 | Apr 2, 2022 | $1.23B | May 20, 2024 |
| FY2023 | Apr 3, 2021 | $906.63M | May 19, 2023 |
| FY2022 | Mar 28, 2020 | $423.22M | May 20, 2022 |
| FY2021 | Mar 30, 2019 | $216.47M | May 24, 2021 |
| FY2019 | Jun 30, 2018 | ($19.22M) | Aug 2, 2018 |
| FY2020 | Mar 31, 2018 | $70.28M | May 20, 2020 |
| FY2019 | Jul 1, 2017 | ($27.83M) | Aug 2, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $747.71M | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $682.25M | May 19, 2025 |
| FY2025 | Apr 1, 2023 | $649.84M | May 19, 2025 |
| FY2024 | Apr 2, 2022 | $623.64M | May 20, 2024 |
| FY2023 | Apr 3, 2021 | $570.40M | May 19, 2023 |
| FY2022 | Mar 28, 2020 | $484.41M | May 20, 2022 |
| FY2021 | Mar 30, 2019 | $450.48M | May 24, 2021 |
| FY2019 | Jun 30, 2018 | $110.90M | Aug 2, 2018 |
| FY2020 | Mar 31, 2018 | $445.10M | May 20, 2020 |
| FY2019 | Jul 1, 2017 | $116.50M | Aug 2, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Mar 30, 2024 | $389.14M | May 20, 2024 |
| FY2024 | Apr 1, 2023 | $358.79M | May 20, 2024 |
| FY2024 | Apr 2, 2022 | $349.72M | May 20, 2024 |
| FY2023 | Apr 3, 2021 | $367.24M | May 19, 2023 |
| FY2022 | Mar 28, 2020 | $343.57M | May 20, 2022 |
| FY2021 | Mar 30, 2019 | $476.07M | May 24, 2021 |
| FY2019 | Jun 30, 2018 | $135.93M | Aug 2, 2018 |
| FY2020 | Mar 31, 2018 | $527.75M | May 20, 2020 |
| FY2019 | Jul 1, 2017 | $139.43M | Aug 2, 2018 |
| FY2018 | Apr 1, 2017 | $545.59M | May 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $622.20M | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $833.19M | May 19, 2025 |
| FY2025 | Apr 1, 2023 | $843.23M | May 19, 2025 |
| FY2024 | Apr 2, 2022 | $1.05B | May 20, 2024 |
| FY2023 | Apr 3, 2021 | $1.30B | May 19, 2023 |
| FY2022 | Mar 28, 2020 | $945.65M | May 20, 2022 |
| FY2021 | Mar 30, 2019 | $810.36M | May 24, 2021 |
| FY2019 | Jun 30, 2018 | $75.26M | Aug 2, 2018 |
| FY2020 | Mar 31, 2018 | $852.52M | May 20, 2020 |
| FY2019 | Jul 1, 2017 | $103.64M | Aug 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $137.60M | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $127.23M | May 19, 2025 |
| FY2025 | Apr 1, 2023 | $158.95M | May 19, 2025 |
| FY2024 | Apr 2, 2022 | $213.47M | May 20, 2024 |
| FY2023 | Apr 3, 2021 | $186.96M | May 19, 2023 |
| FY2022 | Mar 28, 2020 | $164.10M | May 20, 2022 |
| FY2021 | Mar 30, 2019 | $220.94M | May 24, 2021 |
| FY2019 | Jun 30, 2018 | $43.56M | Aug 2, 2018 |
| FY2020 | Mar 31, 2018 | $269.84M | May 20, 2020 |
| FY2019 | Jul 1, 2017 | $124.43M | Aug 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $5.93B | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $6.55B | May 19, 2025 |
| FY2024 | Apr 1, 2023 | $6.69B | May 20, 2024 |
| FY2023 | Apr 2, 2022 | $7.51B | May 19, 2023 |
| FY2022 | Apr 3, 2021 | $7.22B | May 20, 2022 |
| FY2021 | Mar 28, 2020 | $6.56B | May 24, 2021 |
| FY2020 | Mar 30, 2019 | $5.81B | May 20, 2020 |
| FY2019 | Jun 30, 2018 | $5.78B | Aug 2, 2018 |
| FY2019 | Mar 31, 2018 | $6.38B | Aug 2, 2018 |
| FY2018 | Apr 1, 2017 | $6.52B | May 21, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $2.54B | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $3.00B | May 19, 2025 |
| FY2024 | Apr 1, 2023 | $2.79B | May 20, 2024 |
| FY2023 | Apr 2, 2022 | $2.96B | May 19, 2023 |
| FY2022 | Apr 3, 2021 | $2.59B | May 20, 2022 |
| FY2021 | Mar 28, 2020 | $2.27B | May 24, 2021 |
| FY2020 | Mar 30, 2019 | $1.45B | May 20, 2020 |
| FY2019 | Jun 30, 2018 | $1.10B | Aug 2, 2018 |
| FY2019 | Mar 31, 2018 | $1.61B | Aug 2, 2018 |
| FY2018 | Apr 1, 2017 | $1.63B | May 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $3.39B | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $3.56B | May 19, 2025 |
| FY2025 | Apr 1, 2023 | $3.90B | May 19, 2025 |
| FY2025 | Apr 2, 2022 | $4.55B | May 19, 2025 |
| FY2024 | Apr 3, 2021 | $4.63B | May 20, 2024 |
| FY2023 | Mar 28, 2020 | $4.29B | May 19, 2023 |
| FY2022 | Mar 30, 2019 | $4.36B | May 20, 2022 |
| FY2019 | Jun 30, 2018 | $4.68B | Aug 2, 2018 |
| FY2021 | Mar 31, 2018 | $4.78B | May 24, 2021 |
| FY2020 | Apr 1, 2017 | $4.90B | May 20, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $2.39B | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $2.53B | May 19, 2025 |
| FY2024 | Apr 1, 2023 | $2.76B | May 20, 2024 |
| FY2023 | Apr 2, 2022 | $2.78B | May 19, 2023 |
| FY2022 | Apr 3, 2021 | $2.64B | May 20, 2022 |
| FY2021 | Mar 28, 2020 | $2.61B | May 24, 2021 |
| FY2020 | Mar 30, 2019 | $2.17B | May 20, 2020 |
| FY2019 | Jun 30, 2018 | $2.17B | Aug 2, 2018 |
| FY2019 | Mar 31, 2018 | $2.17B | Aug 2, 2018 |
| FY2018 | Apr 1, 2017 | $2.17B | May 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | ($33.98M) | May 19, 2025 |
| FY2025 | Mar 30, 2024 | ($89.60M) | May 19, 2025 |
| FY2025 | Apr 1, 2023 | $84.50M | May 19, 2025 |
| FY2025 | Apr 2, 2022 | $512.14M | May 19, 2025 |
| FY2024 | Apr 3, 2021 | $355.04M | May 20, 2024 |
| FY2023 | Mar 28, 2020 | $0 | May 19, 2023 |
| FY2022 | Mar 30, 2019 | ($321.15M) | May 20, 2022 |
| FY2019 | Jun 30, 2018 | ($484.27M) | Aug 2, 2018 |
| FY2021 | Mar 31, 2018 | ($458.77M) | May 24, 2021 |
| FY2020 | Apr 1, 2017 | ($456.37M) | May 20, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $1.02B | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $1.03B | May 19, 2025 |
| FY2025 | Apr 1, 2023 | $808.76M | May 19, 2025 |
| FY2024 | Apr 2, 2022 | $972.59M | May 20, 2024 |
| FY2023 | Apr 3, 2021 | $1.40B | May 19, 2023 |
| FY2022 | Mar 28, 2020 | $714.94M | May 20, 2022 |
| FY2021 | Mar 30, 2019 | $711.04M | May 24, 2021 |
| FY2019 | Jun 30, 2018 | $334.04M | Aug 2, 2018 |
| FY2019 | Mar 31, 2018 | $926.04M | Aug 2, 2018 |
| FY2018 | Apr 1, 2017 | $545.46M | May 21, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $1.55B | May 19, 2025 |
| FY2025 | Mar 30, 2024 | $1.55B | May 19, 2025 |
| FY2024 | Apr 1, 2023 | $2.05B | May 20, 2024 |
| FY2023 | Apr 2, 2022 | $2.05B | May 19, 2023 |
| FY2022 | Apr 3, 2021 | $1.74B | May 20, 2022 |
| FY2021 | Mar 28, 2020 | $1.57B | May 24, 2021 |
| FY2020 | Mar 30, 2019 | $920.94M | May 20, 2020 |
| FY2019 | Jun 30, 2018 | $558.28M | Aug 2, 2018 |
| FY2019 | Mar 31, 2018 | $983.29M | Aug 2, 2018 |
| FY2018 | Apr 1, 2017 | $989.15M | May 21, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | 0 | May 19, 2025 |
| FY2025 | Mar 30, 2024 | 0 | May 19, 2025 |
| FY2025 | Apr 1, 2023 | 1 | May 19, 2025 |
| FY2024 | Apr 2, 2022 | 9 | May 20, 2024 |
| FY2023 | Apr 3, 2021 | 6 | May 19, 2023 |
| FY2020 | Mar 28, 2020 | 0 | May 20, 2020 |
| FY2020 | Dec 28, 2019 | 1 | May 20, 2020 |
| FY2020 | Sep 28, 2019 | 0 | May 20, 2020 |
| FY2020 | Jun 29, 2019 | 0 | May 20, 2020 |
| FY2020 | Mar 30, 2019 | 0 | May 20, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | 0 | May 19, 2025 |
| FY2025 | Mar 30, 2024 | 0 | May 19, 2025 |
| FY2025 | Apr 1, 2023 | 1 | May 19, 2025 |
| FY2024 | Apr 2, 2022 | 9 | May 20, 2024 |
| FY2023 | Apr 3, 2021 | 6 | May 19, 2023 |
| FY2020 | Mar 28, 2020 | 0 | May 20, 2020 |
| FY2020 | Dec 28, 2019 | 1 | May 20, 2020 |
| FY2020 | Sep 28, 2019 | 0 | May 20, 2020 |
| FY2020 | Jun 29, 2019 | 0 | May 20, 2020 |
| FY2020 | Mar 30, 2019 | 0 | May 20, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | 92.92M | May 19, 2025 |
| FY2025 | Mar 30, 2024 | 95.80M | May 19, 2025 |
| FY2025 | Apr 1, 2023 | 98.65M | May 19, 2025 |
| FY2025 | Apr 2, 2022 | 106.30M | May 19, 2025 |
| FY2024 | Apr 3, 2021 | 112.56M | May 20, 2024 |
| FY2023 | Mar 28, 2020 | 114.63M | May 19, 2023 |
| FY2022 | Mar 30, 2019 | 119.06M | May 20, 2022 |
| FY2019 | Jun 30, 2018 | 125.60M | Aug 2, 2018 |
| FY2021 | Mar 31, 2018 | 126.32M | May 24, 2021 |
| FY2020 | Apr 1, 2017 | 126.46M | May 20, 2020 |